SARS-CoV-2 related HIV, HBV, RSV, VZV, Enteric viruses, Influenza, DENV, S. aureus and TB co-infections

Abstract

SARS-CoV-2 a virulent disease that established the entire wide world due to its severity. Its 1st case was rumored in Wuhan, China within the year 2019 and it had been the beginning of this pandemic. This virus killed virtually a complete of 4,465,683 folks round the globe until date. Despite the fact that viral co-infections have the ability to alter the host’s illness pattern, few research have looked at the disease outcomes in patients who are infected with HIV and hCoVs. Despite the fact that HIV-positive people can be infected with hCoVs, researchers are now revealing that their chances of acquiring serious CoV-related disorders are typically similar to what is seen in the general population. The relation between SARS-CoV-2 and HBV was summarized rather HBV effects the severity of COVID patient or not. SARS-CoV-2 could be a severe acute metabolic process syndrome. Scientists found ways in which to treat this virus, some were useful and alternative weren’t that a lot of effective. Immunizing agent was one among the most important considerations for the entire world. This virus conjointly fashioned an entry for alternative co-infections too. SARS-CoV-2 and influenza virus, both causes respiratory diseases which confer as an extensive array of illness from asymptomatic or benign to critical disease and death. Also the mode of transmission and symptoms of influenza virus and SARS-CoV-2 are same. Viral and bacterial rate is higher in SARS-CoV-2 negative patient but are comparable. Serologies facts confirmed that patients with effective results for dengue virus (DENV) NS1 antigen and anti-dengue IgM were also attentive to COVID-19 speedy antibody tests, suggesting dengue COVID-19 co-infection. Mixed infection of dengue and COVID-19 needs unique interest from all dengue-common nations in Asia, especially the ones with limited resources. To our knowledge, this is the primary showed case of co-infection of dengue and COVID-19 in Indonesia. During patient’s TB course, COVID-19 can occur at any time with worse consequences for the patients who are affected by active pulmonary disease.

The Optimal Strategies to Be Adopted in Controlling the Co-Circulation of COVID-19, Dengue and HIV: Insight from a Mathematical Model

“…Co-infection between dengue and COVID-19 has been reported in different parts of the world. Patients suffering from dual infections of dengue and COVID-19 could suffer severe illness [13].…”

Targeted Isolation of Antiviral Labdane Diterpenes from the Bark of Neo-uvaria foetida (Annonaceae) using LC-MS/MS-Based Molecular Networking

“…Difficult diagnosis can be due to overlapping symptoms, 10 and infection of SARS-CoV-2 and arboviruses may result in severe illness and increased death rates among infected patients. 11 Despite the availability of vaccines for COVID-19, the durability of immune protection remains uncertain, and breakthrough infections have been reported. 12,13 This highlights the ongoing need for effective antiviral agents that can provide therapeutic options, particularly in the context of potential coinfections with other viruses like ZIKV.…”

“…Both COVID-19 and ZIKV are prevalent in many tropical and subtropical regions, such as Thailand, Indonesia, Singapore (Southeast Asia), and Brazil (Latin America). Difficult diagnosis can be due to overlapping symptoms, and infection of SARS-CoV-2 and arboviruses may result in severe illness and increased death rates among infected patients …”